 Researchers used multi-disciplinary approach to design NNRTIs with better resistance profile and an increased genetic barrier to the development of resistance.A new class of compounds, diarylpyrimide (DAPY), were discovered with the replacement of the central triazine ring from the DATA compounds, with a pyrimidine.This new class was more effective against drug resistant HIV-1 strains than the corresponding DATA analogs.